Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
MnSOD-Ac-ROS-HIF2a 轴的失调促进 IR/顺铂耐药表型
基本信息
- 批准号:9262705
- 负责人:
- 金额:$ 39.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAddressAffectAgarAllograftingApplications GrantsBiochemistryCell physiologyCellsCellular biologyChemical ExposureCisplatinComplexCytotoxic ChemotherapyDataDeacetylationDrug Metabolic DetoxicationEnzymesEquilibriumEventExhibitsGeneticGenomic InstabilityGrowthIn VitroIonizing radiationLaboratoriesLeadLinkLysineMalignant NeoplasmsMetabolicMetabolic stressMethodsMitochondriaModelingModificationMolecular BiologyMusOncogenicOncoproteinsOxidative StressPathway interactionsPeroxidasesPhenotypePhysiologicalPost-Translational Protein ProcessingProcessProtein AcetylationProteinsRadiation exposureRadioresistanceReactive Oxygen SpeciesResearch ProposalsResistanceRoleSOD2 geneSeriesSignal TransductionSiteSuperoxidesTechniquesTherapeuticTumor Suppressor ProteinsTumor stageValidationXenograft ModelXenograft procedurebasechemotherapeutic agentdensityin vivoinnovationknock-downmimeticsmitochondrial metabolismmouse modelmutantneoplastic cellnovel therapeutic interventionoverexpressionpermissivenesspreventradioresistanttargeted treatmenttissue/cell culturetumortumor initiationtumorigenesis
项目摘要
Summary - Metabolic stress, a hallmark of cancer, is an early event in tumorigenesis that
accumulates in the cell from endogenous processes, exogenous conditions, and/or agents that
induce oxidative stress. Additionally, the aberrant accumulation of reactive oxygen species (ROS),
as well as altered mitochondrial metabolism (i.e., oxidative or metabolic stress), are early events in
the process of cellular reprogramming that under specific conditions leads to tumor cell resistance.
It has become increasingly clear that lysine acetylation (i.e., mitochondrial Acetylome) is the
primary post-translational modification employed by the mitochondrial to sense changes in ROS
and/or metabolic conditions and initial adaptive or reparative signaling processes, including
metabolic reprogramming to maintain homeostatic poise. While a link between the dysregulation of
the mitochondrial Acetylome, ROS detoxification (i.e., metabolic stress), and metabolic
reprogramming leading to tumor cell resistance has long been suggested, rigorous mechanistic
data to supporting this intriguing idea has been limited. In this grant application it is proposed that
the acetylation status of manganese superoxide dismutase (MnSOD), a critical mitochondrial
enzyme, directs detoxification activity as well as connects metabolic stress and mitochondrial
reparative pathways that maintain metabolic fidelity. In this regard, it is proposed that MnSOD
exhibits a dichotomous function, based on the acetylation status of K68, where the homotetrameric
form acts as a protective detoxification enzyme against aberrant ROS levels. In contrast, K68
acetylation inhibits the homotetrameric complex and MnSOD subsequently forms a monomeric
protein form that is proposed to function as an oncoprotein. Thus, it is proposed that the
dysregulation MnSOD axis, due to acetylation, alters MnSOD function which subsequently
reprograms mitochondria resulting in a tumor cell anti-cancer resistance therapy phenotype. In
addition, targeted the acetylation status or restoring the MnSOD functions will be used to generate
and validation of new therapeutic strategies to sensitize tumor cells to cytotoxic therapies
摘要-代谢应激是癌症的一个标志,是肿瘤发生的早期事件,
通过内源性过程、外源性条件和/或以下因素在细胞中积累
诱导氧化应激。此外,活性氧物种(ROS)的异常积累,
以及线粒体代谢改变(即氧化或代谢应激),都是
在特定条件下导致肿瘤细胞耐药的细胞重编程过程。
越来越清楚的是,赖氨酸乙酰化(即线粒体乙酰化)是
线粒体用来感知ROS变化的初级翻译后修饰
和/或代谢条件和初始适应或修复信号过程,包括
新陈代谢重新编程以维持体内平衡平衡。而监管失调之间的联系
线粒体乙酰组、ROS解毒(即代谢应激)和代谢
长期以来,重新编程导致肿瘤细胞耐药一直被认为是严格的机制
支持这一耐人寻味的想法的数据有限。在这项赠款申请中,建议
线粒体关键酶--锰超氧化物歧化酶的乙酰化状态
酶,指导解毒活性,连接代谢应激和线粒体
维持代谢保真度的修复途径。在这方面,建议将MnSOD
基于K68的乙酰化状态,显示出二分功能,其中同源四聚体
Form作为一种保护性解毒酶来对抗异常的ROS水平。相比之下,K68
乙酰化抑制同源四聚体复合体,而MnSOD随后形成单体
被认为具有癌蛋白功能的蛋白质形式。因此,建议将
由于乙酰化引起的MnSOD轴调节失调,改变了MnSOD的功能,从而
线粒体重新编程,形成肿瘤细胞抗癌耐药治疗表型。在……里面
此外,针对乙酰化状态或恢复MnSOD功能将用于生成
以及验证使肿瘤细胞对细胞毒治疗敏感的新治疗策略
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Gius其他文献
David Gius的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Gius', 18)}}的其他基金
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
由于 MnSOD 生物学的破坏,谱系可塑性驱动了对电离辐射/雄激素剥夺疗法的抵抗
- 批准号:
10737810 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
由于 MnSOD 生物学的破坏,谱系可塑性驱动了对电离辐射/雄激素剥夺疗法的抵抗
- 批准号:
10533472 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
由于 MnSOD 生物学的破坏,谱系可塑性驱动了对电离辐射/雄激素剥夺疗法的抵抗
- 批准号:
10390451 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
MnSOD-K68-Ac 重新编程 ER 乳腺恶性肿瘤中的谱系可塑性开关/干性
- 批准号:
10327336 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
MnSOD-K68-Ac 重新编程 ER 乳腺恶性肿瘤中的谱系可塑性开关/干性
- 批准号:
10541193 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy
由于 MnSOD 生物学的破坏,谱系可塑性驱动了对电离辐射/雄激素剥夺疗法的抵抗
- 批准号:
10548835 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
MnSOD-Ac-ROS-HIF2a 轴的失调促进 IR/顺铂耐药表型
- 批准号:
10335424 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies.
MnSOD-K68-Ac 重新编程 ER 乳腺恶性肿瘤中的谱系可塑性开关/干性。
- 批准号:
10817556 - 财政年份:2021
- 资助金额:
$ 39.65万 - 项目类别:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
MnSOD-Ac-ROS-HIF2a 轴的失调促进 IR/顺铂耐药表型
- 批准号:
10024964 - 财政年份:2017
- 资助金额:
$ 39.65万 - 项目类别:
Dys-regulation of the MnSOD-Ac-ROS-HIF2a axis promotes IR / Cisplatin resistance phenotype
MnSOD-Ac-ROS-HIF2a 轴的失调促进 IR/顺铂耐药表型
- 批准号:
9889066 - 财政年份:2017
- 资助金额:
$ 39.65万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 39.65万 - 项目类别:
Research Grant














{{item.name}}会员




